Afya (NASDAQ:AFYA) Research Coverage Started at UBS Group

Stock analysts at UBS Group began coverage on shares of Afya (NASDAQ:AFYA) in a note issued to investors on Thursday, September 19th, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $29.00 price target on the stock. UBS Group’s price objective points to a potential upside of 13.81% from the company’s previous close.

A number of other analysts also recently issued reports on AFYA. JPMorgan Chase & Co. initiated coverage on Afya in a research report on Friday, August 9th. They issued an “overweight” rating and a $34.00 price target for the company. Bank of America initiated coverage on Afya in a research report on Tuesday, August 13th. They set a “buy” rating and a $29.00 target price for the company. Morgan Stanley initiated coverage on Afya in a research report on Tuesday, August 13th. They set an “overweight” rating and a $29.20 target price for the company. Finally, Goldman Sachs Group initiated coverage on Afya in a research report on Tuesday, August 13th. They set a “neutral” rating and a $26.00 target price for the company. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $29.37.

Shares of NASDAQ AFYA traded up $0.38 during midday trading on Thursday, reaching $25.48. 49,161 shares of the stock traded hands, compared to its average volume of 289,132. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.61 and a current ratio of 0.61. Afya has a one year low of $21.30 and a one year high of $32.64. The stock has a 50 day moving average of $25.41.

Afya (NASDAQ:AFYA) last posted its earnings results on Friday, August 30th. The company reported $3.38 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $3.24. The firm had revenue of $45.55 million for the quarter, compared to the consensus estimate of $47.99 million. As a group, equities analysts predict that Afya will post 0.58 EPS for the current fiscal year.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Recommended Story: What is insider trading?

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.